Exposure to mycotoxins and malignant tumors;Moguca povezanost izlozenosti mikotoksinima s nastankom malignih bolesti

Arhiv za Higijenu Rada i Toksikologiju

Volumn 51, Issue SUPPL. 1, 2000, Pages 131-139

  Peraica, M ^a   Plestina, R ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

Aflatoxins; Fumonisins; Lipid metabolism; Liver cancer; Nephropathy; Ochratoxins; Oesophageal cancer; Urothelial tumours

Indexed keywords

AFLATOXIN B1; AFLATOXIN M1; CARCINOGEN; FUMONISIN B1; MYCOTOXIN; OCHRATOXIN;

CANCER INCIDENCE; CARCINOGENESIS; CONFERENCE PAPER; ESOPHAGUS CANCER; HUMAN; KIDNEY DISEASE; LIPID METABOLISM; LIVER CANCER; MALIGNANT NEOPLASTIC DISEASE; POPULATION EXPOSURE; URBAN POPULATION;

EID: 0033881378     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Hepatitis due to aflatoxicosis. An outbreak in Western India
2. Study of an epidemic of jaundice, presumably due to toxic hepatitis in parts of Western India
3. Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya
4. Aflatoxin inhalation and alveolar cell carcinoma
5. Aflatoxin exposures in the industrial setting: An epidemiological study of mortality
6. Overall evaluations of carcinogenicity: An updating of IARC monographs volumes 1 to 42
7. DNA damage by mycotoxins
8. Dietary aflatoxins and human liver cancer. III Field survey of rural Thai families for ingested aflatoxins
9. Dietary aflatoxins and liver cancer - a population study in Kenya
10. Primary liver cancer rate and aflatoxin intake in a high cancer area
11. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei
12. Carcinogenesis and prevention strategy of liver cancer in areas of prevalence
13. Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China
14. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland
15. Hepatocellular carcinoma: From gene to public health
16. Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins
17. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan
18. Selected mycotoxins: Ochratoxins, trichothecenes, ergot
19. Inhaled mycotoxins lead to acute renal failure
20. Mycotoxic porcine nephropathy: A possible model for Balkan endemic nephropathy
21. Some features of Balkan endemic nephropathy
22. Ochratoxin A contamination of foodstuffs
23. Ochratoxin A in human blood and Balkan endemic nephropathy
24. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia
25. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary tract tumours in Bulgaria
26. The occurrence of ochratoxin A in blood in general population of Croatia
27. Occurrence and estimated dietary intakes of ochratoxin A in European countries: Results from a SCOOP project
28. Epidemiological aspects of Balkan endemic nephropathy in a typical focus in Yugoslavia
29. Balkan endemic nephropathy and the associated tumours of the urinary system: A summary of epidemiological features in Bulgaria
30. Epidemiological characteristics of Balkan endemic nephropathy in eastern regions of Yugoslavia
31. Chromatographic determination of the fumonisin mycotoxins
32. Chromatographic and allied methods of analysis for selected mycotoxins
33. 1 and other mycotoxins in moldy corn collected from People's Republic of China in regions with high incidences of esophageal cancer
34. Incidence and levels of fumonisin contamination in maize genotypes grown in Europe and Africa
35. 1 in maize-containing foods in The Netherlands
36. 1 in male Sprague-Dawley rats
37. 1
38. 1
39. 1 isolated from Fusarium moniliforme
40. Characterization of an epizootic of pulmonary edema in swine associated with fumonisin in corn screenings
41. 1, in rats
42. Toxicity of Fusarium proliferatum-fermented nixtamalized corn-based diets fed to rats: Effect of nutritional status
43. 1 in rat liver using diethylnitrosamine as a cancer initiator
44. Toxic effects of mycotoxins in humans
45. Fumonisins and other inhibitors of de novo sphingolipid biosynthesis
46. Liquid chromatographic determination of sphinganine and sphingosine: Use of the free sphinganine-to-sphingosine ratio as a biomarker for consumption of fumonisins
47. Increases in serum sphingonine and sphinganine and decrease in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme
48. Alteration of tissue and serum sphinganine to sphinogosine ratio: An early biomarker of exposure to fumonisin-containing feeds in pigs